The ubiquitin-proteasome system and neurodegenerative disorders

Essays in Biochemistry

Volumn 41, Issue , 2005, Pages 157-171

  Layfield, Robert ^a,b   Lowe, James ^a,b   Bedford, Lynn ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

EID: 27144512435     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/eb0410157     Document Type: Review

References (50)

1. Ehlers, M.D. (2003) Activity level controls postsynaptic composition and signalling via the ubiquitin-proteasome system. Nat. Neurosci. 6, 231-242
2. Speese, S.D., Trotta, N., Rodesch, C.K., Aravamudan, B. & Broadie, K. (2003) The ubiquitin proteasome system regulates presynaptic protein turnover and synaptic efficacy. Curr. Biol. 13, 899-910
3. Zhao, Y., Hegde, A.N. & Martin, K.C. (2003) The ubiquitin proteasome system functions as an inhibitory constraint on synaptic strengthening. Curr. Biol. 13, 887-898
4. Hegde, A.N., Inokuchi, K., Pei, W., Casadio, A., Ghirardi, M., Chain, D.G., Martin, K.C., Kandel, E.R. & Schwartz, J.H. (1997) Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell 89, 115-126
5. Verma, P., Chierzi, S., Codd, A.M., Campbell, D.S., Meyer, R.L., Holt, C.E. & Fawcett, J.W. (2005) Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration. J. Neurosci. 25, 331-342
6. Goate, A., Chartier-Harlin M.C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L. et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature (London) 349, 704-706
7. Hutton, M., Lendon, C.L, Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A. et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (London) 393, 702-705
8. Mori, H., Kondo, J. & Ihara, Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644
9. Perry, G., Friedman, R., Shaw, G. & Chau, V. (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. U.S.A. 84, 3033-3036
10. Probst, A.M.C., Herzig, M.C., Mistl, C., Ipsen, S. & Tolnay, M. (2001) Perisomatic granules (non-plaque dystrophic dendrites) of hippocampal CAI neurons in Alzheimer's disease and Pick's disease: a lesion distinct from granulovacuolar degeneration. Acta Neuropathol. 102, 636-644
11. Dickson, D.W., Wertkin, A., Kress, Y., Ksiezak-Reding, H. & Yen, S.H. (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab. Invest. 63, 87-99
12. Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M. & Mayer, R.J. (1988) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease. J. Pathol. 155, 9-15
13. Lowe, J., Lennox, G., Jefferson, D., Morrell, K., McQuire, D., Gray, T., Landon, M., Doherty, F.J. & Mayer, R.J. (1988) A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci. Lett 94, 203-210
14. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P. & Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993
15. McKeith, I.G., Galasko, D., Kosaka, K., Perry, E.K., Dickson, D.W., Hansen, LA., Salmon, D.P., Lowe, J., Mirra, S.S., Byrne, E.J. et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124
16. McKeith, I.G., Perry, E.K. & Perry, R.H. (1999) Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on dementia with Lewy bodies. Neurology 53, 902-905
17. Leigh, P.N., Anderton, B.H., Dodson, A., Gallo, J.M., Swash, M. & Power D.M. (1988) Ubiquitin deposits in anterior horn cells in motor neurone disease Neurosci. Lett. 93, 197-203
18. Jackson, M., Lennox, G. & Lowe, J. (1996) Motor neurone disease-inclusion dementia. Neurodegeneration 5, 339-350
19. Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K. & Ihara, Y. (1993) Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments. Neuron 10, 1151-1160
20. Sampathu, D.M., Giasson, B.I., Pawlyk, A.C., Trojanowski, J.Q. & Lee, V.M. (2003) Ubiquitination of α-synuclein is not required for formation of pathological inclusions in α-synucleinopathies. Am. J. Pathol. 163, 191-100
21. Johnston, J.A., Ward, C.L. & Kopito, R.R. (1998) Aggresomes: a cellular response to misfolded proteins. J. Cell Biol. 143, 1883-1898
22. Olanow, C.W., Perl, D.P., DeMartino, G.N. & McNaught, K.S. (2003) Lewy-body formation is an aggresome-related process: a hypothesis. Lancet Neurol. 3, 496-503
23. Shimura, H., Schlossmacher, M.G., Hattori, N., Frosch, M.P., Trockenbacher, A., Schneider, R., Mizuno, Y., Kosik, K.S. & Selkoe, D.J. (2001) Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269
24. Chung, K.K., Zhang, Y., Lim, K.L., Tanaka, Y., Huang, H., Gao, J., Ross, C.A., Dawson, V.L. & Dawson, T.M. (2001) Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7, 1144-1150
25. Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L. & Dawson, T.M. (2000) Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. U.S.A. 97, 13354-13359
26. Corti, O., Hampe, C., Koutnikova, H., Darios, F., Jacquier, S., Prigent, A., Robinson, J.C., Pradier, L., Ruberg, M., Mirande, M. et al. (2003) The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum. Mol. Genet. 12, 1427-1437
27. Huynh, D.P., Scoles, D.R., Nguyen, D. & Pulst, S.M. (2003) The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum. Mol. Genet. 12, 2587-2597
28. Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y. & Takahashi, R. (2001) An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell 105, 891-902
29. Staropoli, J.F., McDermott, C., Martinat, C., Schulman, B., Demireva, E. & Abeliovich, A. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749
30. Goldberg, M.S., Fleming, S.M., Palacino, J.J., Cepeda, C., Lam, H.A., Bhatnagar, A., Meloni, E.G., Wu, N., Ackerson, L.C., Klapstein, G.J., et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J. Biol. Chem. 278, 43628-43635
31. Lim, K.L., Chew, K.C., Tan, J.M., Wang, C., Chung, K.K., Zhang, Y., Tanaka, Y., Smith, W., Engelender, S., Ross, C.A., Dawson, V.L. & Dawson, T.M. (2005) Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002-2009
32. Mata, I.F., Lockhart, P.J. & Farrer, M.J. (2004) Parkin genetics: one model for Parkinson's disease. Hum. Mol. Genet. 13, R127-R133
33. Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M.J., Jonnalagada, S., Chernova, T., et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature (London) 395, 451-452
34. Saigoh, K., Wang, Y.L., Suh, J.G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T. & Wada, K. (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 23, 47-51
35. Liu, Y., Fallon, L., Lashuel, H.A., Liu, Z. & Lansbury, Jr, P.T. (2002) The UCH-LI gene encodes two opposing enzymatic activities that affect α-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218
36. Van Leeuwen, F.W., de Kleijn, D.P., Van den Hurk, H.H., Neubauer, A., Sonnemans, M.A., Sluijs, J.A., Koycu, S., Ramdjielal, R.D., Salehi, A., Martens, G.J. et al. (1998) Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 279, 242-247
37. Fischer, D.F., De Vos, R.A., Van Dijk, R., De Vrij, F.M., Proper, E.A., Sonnemans, M.A., Verhage, M.C., Sluijs, J.A., Hobo, B., Zouambia, M. et al. (2003) Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J. 17, 2014-2024
38. Lam, Y.A., Pickart, C.M., Alban, A., Landon, M., Jamieson, C., Ramage, R., Mayer, R.J. & Layfield R. (2000) Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 97, 9902-9906
39. Song, S., Kim, S.Y., Hong, Y.M., Jo, D.G., Lee, J.Y., Shim, S.M., Chung, C.W., Seo, S.J., Yoo, Y.J., Koh, J.Y. et al. (2003) Essential role of E2-25K/Hip-2 in mediating amyloid-β neurotoxicity. Mol. Cell 12, 553-563
40. De Pril, R., Fischer, D.F., Maat-Schieman, M.L., Hobo, B., De Vos, R.A., Brunt, E.R., Hol, E.M., Roos, R.A. & Van Leeuwen F.W. (2004) Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. Hum. Mol. Genet. 13, 1803-1813
41. Gray, D.A. (2001) Damage control - a possible non-proteolytic role for ubiquitin in limiting neurodegeneration. Neuropathol. Appl. Neurobiol. 27, 89-94
42. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66
43. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R. & Finkbeiner, S. (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (London) 431, 805-810
44. Webb, J.L., Ravikumar, B., Atkins, J., Skepper, J.N. & Rubinsztein, D.C. (2003) α-synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009-25013
45. Shimura, H., Schwartz, D., Gygi, S.P. & Kosik, K.S. (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869-4876
46. Fergusson, J., Landon, M., Lowe, J., Dawson, S.P., Layfield, R., Hanger, D.P. & Mayer, R.J. (1996) Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26 S proteasome. Neurosci. Lett. 219, 167-170
47. Bennett, E.J., Bence, N.F., Jayakumar, R. & Kopito, R.R. (2005) Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17, 351-365
48. Gregori, L., Hainfeld, J.F., Simon, M.N. & Goldgaber, D. (1997) Binding of amyloid beta protein to the 20 S proteasome. J. Biol. Chem. 272, 58-62
49. Keck, S., Nitsch, R., Grune, T. & Ullrich O. (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85, 115-122
50. Thrower, J.S., Hoffman, L., Rechsteiner, M. & Pickart, C.M. (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102